Toggle navigation
Home
Search
Services
Blog
Contact
About
Warfarin Therapy Using Computer Assisted Guidance
Wurster, Mark W.
Standing Stone, Inc., Westport, CT, United States
Search grants from Mark Wurster
Search grants from Standing Stone, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular Determinants of Faithful Chromosome Transmissi
Tyloindicines: Chemistry and Biology
Hydrogen Peroxide Sensing by Human Endothelial Cells
Colonic Putative Preneoplastic Foci
DNA-Protein Interactions of Telomeres in Yeast
Recently added grants:
The ion channel TRPA1 is required for suppression of inflammation in sepsis
Small RNAs and telomere biology
PED Screen: Pediatric Sepsis EHR Registry, Clinical Outcomes, and Predictive Model
Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices
Boston University Conference on Language Development
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43HL069579-01S1
Application #
7871759
Study Section
Special Emphasis Panel (ZRG1-HEM-1 (10))
Program Officer
Hasan, Ahmed AK
Project Start
2009-06-15
Project End
2009-09-14
Budget Start
2009-06-15
Budget End
2009-09-14
Support Year
1
Fiscal Year
2004
Total Cost
$19,153
Indirect Cost
Institution
Name
Standing Stone, Inc.
Department
Type
DUNS #
City
Westport
State
CT
Country
United States
Zip Code
06880
Related projects
NIH 2004
R43 HL
Warfarin Therapy Using Computer Assisted Guidance
Wurster, Mark W. / Standing Stone, Inc.
$19,153
NIH 2002
R43 HL
Warfarin Therapy Using Computer Assisted Guidance
Wurster, Mark W. / Standing Stone, Inc.
$88,043
Publications
Gordon, Adam S; Fulton, Robert S; Qin, Xiang et al.
(2016)
PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation.
Pharmacogenet Genomics :
Comments
Be the first to comment on Mark Wurster's grant